Versant Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$794 Sell
61
-137
-69% -$1.78K ﹤0.01% 2512
2025
Q1
$2.1K Buy
198
+142
+254% +$1.5K ﹤0.01% 2264
2024
Q4
$950 Hold
56
﹤0.01% 2207
2024
Q3
$1.3K Buy
+56
New +$1.3K ﹤0.01% 1680